Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Publisher : cancer intelligence

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Repurposing Drugs in Oncology (ReDO)--chloroquine and hydroxychloroquine as anti-cancer agents.

Authors : Verbaanderd, Ciska^1,2,3; Maes, Hannelore²; Schaaf, Marco B.²

Source: Ecancermedicalscience. 2017, Vol. 11 Issue 770-791, p1-35. 35p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Repurposing of drugs for triple negative breast cancer: an overview.

Authors : Spini, Andrea^1,2; Donnini, Sandra³; Pantziarka, Pan^4,5

Source: Ecancermedicalscience. 2020, Vol. 14 Issue 1063-1111, p1-33. 33p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Eribulin-induced radiation recall dermatitis: a case report and brief review of the literature.

Authors : Tran, William T.¹; Ibáñez, Carolina²; Pinto, Mauricio P.²

Source: Ecancermedicalscience. 2020, Vol. 14 Issue 996-1019, p1-5. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent.

Authors : Van Nuffel, An M. T.¹; Sukhatme, Vidula²; Pantziarka, Pan^1,3

Source: Ecancermedicalscience. 2015, Vol. 9 Issue 496-518, p1-26. 26p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Cancer treatment in the last 6 months of life: when inaction can outperform action.

Authors : Gyawali, Bishal¹ ; Niraula, Saroj²

Source: Ecancermedicalscience. 2018, Vol. 12 Issue 819-843, p1-5. 5p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evidence on the cost of breast cancer drugs is required for rational decision making.

Authors : Berghuis, Anne Margreet Sofie¹; Koffijberg, Hendrik¹; Mathias Marie Terstappen, Leonardus Wendelinus²

Source: Ecancermedicalscience. 2018, Vol. 12 Issue 819-843, p1-10. 10p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Repurposing drugs in oncology (ReDO)--selective PDE5 inhibitors as anti-cancer agents.

Authors : Pantziarka, Pan^1,2 ; Sukhatme, Vidula³; Crispino, Sergio¹

Source: Ecancermedicalscience. 2018, Vol. 12 Issue 819-843, p1-22. 22p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges.

Authors : Gentille, Cesar¹ ; Qian Qin¹; Barbieri, Andreia²

Source: Ecancermedicalscience. 2017, Vol. 11 Issue 770-791, p1-8. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Highlights from the WIN 2017 Symposium, 26-27 June 2017, Paris, France: 'Expediting Global Innovation in Precision Cancer Medicine'.

Authors : Davies, Will¹

Source: Ecancermedicalscience. 2017, Vol. 11 Issue 770-791, p1-7. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments.

Authors : van Harten, Wim^1,2,3,4 ; IJzerman, Maarten J.^2,5

Source: Ecancermedicalscience. 2017, Vol. 11 Issue 752-769, p1-4. 4p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Repurposing Drugs in Oncology (ReDO)--chloroquine and hydroxychloroquine as anti-cancer agents.

Repurposing of drugs for triple negative breast cancer: an overview.

Eribulin-induced radiation recall dermatitis: a case report and brief review of the literature.

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent.

Cancer treatment in the last 6 months of life: when inaction can outperform action.

Evidence on the cost of breast cancer drugs is required for rational decision making.

Repurposing drugs in oncology (ReDO)--selective PDE5 inhibitors as anti-cancer agents.

Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges.

Highlights from the WIN 2017 Symposium, 26-27 June 2017, Paris, France: 'Expediting Global Innovation in Precision Cancer Medicine'.

Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments.

اتصل بنا

اتبع